116 related articles for article (PubMed ID: 21170498)
21. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of long non-coding RNA HOTAIR predicts poor patient prognosis and promotes tumor metastasis in epithelial ovarian cancer.
Qiu JJ; Lin YY; Ye LC; Ding JX; Feng WW; Jin HY; Zhang Y; Li Q; Hua KQ
Gynecol Oncol; 2014 Jul; 134(1):121-8. PubMed ID: 24662839
[TBL] [Abstract][Full Text] [Related]
23. [Expression of Notch1, Jagged1 and NICD in epithelial ovarian carcinomas and a preliminary study on the activity of gamma-secretase in epithelial ovarian carcinoma cell lines].
Feng Z; Wen H; Liao Q
Zhonghua Fu Chan Ke Za Zhi; 2014 Oct; 49(10):780-6. PubMed ID: 25537253
[TBL] [Abstract][Full Text] [Related]
24. Genetic determinants of FOXM1 overexpression in epithelial ovarian cancer and functional contribution to cell cycle progression.
Barger CJ; Zhang W; Hillman J; Stablewski AB; Higgins MJ; Vanderhyden BC; Odunsi K; Karpf AR
Oncotarget; 2015 Sep; 6(29):27613-27. PubMed ID: 26243836
[TBL] [Abstract][Full Text] [Related]
25. Formyl peptide receptor 2 expression predicts poor prognosis and promotes invasion and metastasis in epithelial ovarian cancer.
Xie X; Yang M; Ding Y; Yu L; Chen J
Oncol Rep; 2017 Dec; 38(6):3297-3308. PubMed ID: 29039544
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of tumor necrosis factor receptor-associated protein 1 (TRAP1) are associated with poor prognosis of epithelial ovarian cancer.
Lv Q; Sun H; Cao C; Gao B; Qi Y
Tumour Biol; 2016 Feb; 37(2):2721-7. PubMed ID: 26408177
[TBL] [Abstract][Full Text] [Related]
27. High level of WAVE1 expression is associated with tumor aggressiveness and unfavorable prognosis of epithelial ovarian cancer.
Zhang J; Tang L; Shen L; Zhou S; Duan Z; Xiao L; Cao Y; Mu X; Zha L; Wang H
Gynecol Oncol; 2012 Oct; 127(1):223-30. PubMed ID: 22721732
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of normal-sized ovary in advanced serous epithelial ovarian cancer.
Paik ES; Kim JH; Kim TJ; Lee JW; Kim BG; Bae DS; Choi CH
J Gynecol Oncol; 2018 Jan; 29(1):e13. PubMed ID: 29185271
[TBL] [Abstract][Full Text] [Related]
29. The inflammatory microenvironment in epithelial ovarian cancer: a role for TLR4 and MyD88 and related proteins.
Li Z; Block MS; Vierkant RA; Fogarty ZC; Winham SJ; Visscher DW; Kalli KR; Wang C; Goode EL
Tumour Biol; 2016 Oct; 37(10):13279-13286. PubMed ID: 27460076
[TBL] [Abstract][Full Text] [Related]
30. Immunohistological insight into the correlation between neuropilin-1 and epithelial-mesenchymal transition markers in epithelial ovarian cancer.
Adham SA; Al Harrasi I; Al Haddabi I; Al Rashdi A; Al Sinawi S; Al Maniri A; Ba-Omar T; Coomber BL
J Histochem Cytochem; 2014 Sep; 62(9):619-31. PubMed ID: 24850663
[TBL] [Abstract][Full Text] [Related]
31. The role of RhoC in ovarian epithelial carcinoma: a marker for carcinogenesis, progression, prognosis, and target therapy.
Zhao Y; Zheng HC; Chen S; Gou WF; Xiao LJ; Niu ZF
Gynecol Oncol; 2013 Sep; 130(3):570-8. PubMed ID: 23764197
[TBL] [Abstract][Full Text] [Related]
32. Expression of orphan GPR56 correlates with tumor progression in human epithelial ovarian cancer.
Liu Z; Huang Z; Yang W; Li Z; Xing S; Li H; Hu B; Li P
Neoplasma; 2017; 64(1):32-39. PubMed ID: 27881002
[TBL] [Abstract][Full Text] [Related]
33. PSMB4 expression associates with epithelial ovarian cancer growth and poor prognosis.
Liu R; Lu S; Deng Y; Yang S; He S; Cai J; Qiang F; Chen C; Zhang W; Zhao S; Qian L; Mao G; Wang Y
Arch Gynecol Obstet; 2016 Jun; 293(6):1297-307. PubMed ID: 26439929
[TBL] [Abstract][Full Text] [Related]
34. MMP-1-PAR1 axis mediates LPA-induced epithelial ovarian cancer (EOC) invasion.
Wang FQ; Fisher J; Fishman DA
Gynecol Oncol; 2011 Feb; 120(2):247-55. PubMed ID: 21093894
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
[TBL] [Abstract][Full Text] [Related]
36. NEDD9 overexpression is associated with the progression of and an unfavorable prognosis in epithelial ovarian cancer.
Wang H; Mu X; Zhou S; Zhang J; Dai J; Tang L; Xiao L; Duan Z; Jia L; Chen S
Hum Pathol; 2014 Feb; 45(2):401-8. PubMed ID: 24439227
[TBL] [Abstract][Full Text] [Related]
37. Relations between GPR4 expression, microvascular density (MVD) and clinical pathological characteristics of patients with epithelial ovarian carcinoma (EOC).
Ren J; Jin W; Gao YE; Zhang Y; Zhang X; Zhao D; Ma H; Li Z; Wang J; Xiao L; Liu R; Chen Y; Qian J; Niu L; Wei H; Liu Y
Curr Pharm Des; 2014; 20(11):1904-16. PubMed ID: 23888957
[TBL] [Abstract][Full Text] [Related]
38. [Serum level and expression of vascular epithelial growth factor in ovarian epithelial carcinoma].
Sun LX; Wu Y; Han HQ; Wang QH
Ai Zheng; 2003 Jan; 22(1):58-61. PubMed ID: 12561438
[TBL] [Abstract][Full Text] [Related]
39. Over-expression of Sirt1 contributes to chemoresistance and indicates poor prognosis in serous epithelial ovarian cancer (EOC).
Shuang T; Wang M; Zhou Y; Shi C
Med Oncol; 2015 Dec; 32(12):260. PubMed ID: 26520143
[TBL] [Abstract][Full Text] [Related]
40. [Expressions of CD133, E-cadherin, and Snail in epithelial ovarian cancer and their clinicopathologic and prognostic implications].
Yu L; Zhou L; Wu S; Song W; Cheng Z; Guo B
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Aug; 35(9):1297-302. PubMed ID: 26403742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]